-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-233-diverticulitis-evidence-summary.pdf
October 01, 2020 - Evidence Summary: Management of Colonic Diverticulitis
Comparative Effectiveness Review
Number 233
Management of Colonic Diverticulitis
Evidence Summary
Main Points
• Computed tomography (CT) diagnosis and clinical sequelae
o CT accurately diagnoses acute diverticulitis (moderate strength o…
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
December 01, 2015 - binge-drinking behaviors.15
Researchers found that patients in the SA+F group reported fewer binge-drinking days … , while
patients in control and SA groups reported increased numbers of drinking days. … Additionally, after 3
months, significantly fewer SA+F group patients reported any binge drinking days
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/tympanostomy-tubes_research-protocol.pdf
November 16, 2015 - Acute otorrhea is common after tympanostomy tube placement.15 Postoperative otorrhea
(up to 30 days … Criteria
For all KQs, the Eligibility Criteria will be:
Populations
All KQs: Ages: infant (28 days … definitions of “postoperative period,”
but use as a standard definition otorrhea occurring more than 30 days
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
April 01, 2010 - Additional inclusion criteria included being alive 30 days post
diagnosis and having at least one outpatient … outpatient visits at Johns Hopkins or at least two outpatient visits and a hospitalization of
at 3-30 days … For the patients’ last cancer-related
hospitalization, both sites abstracted the first 3 days of the
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
July 01, 2013 - topiramate and mid-titration (maintenance) daily dosage of 7.5
mg phentermine and 46 mg topiramate for 30 days
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0404_01-14-2011.pdf
January 01, 2011 - Effective Health Care
Topic Number: 0340
Document Completion Date: 3-23-11
1
Results of Topic Selection Process & Next Steps
Pulmonary arterial hypertension (PAH) will go forward for refinement as a systematic review. The
scope of this topic, including populations, interventions, comparator…
-
effectivehealthcare.ahrq.gov/sites/default/files/nt_docs/topic-brief-updating-pharmacotherapy.pdf
September 30, 2022 - Consumption outcomes
1. abstinence/any drinking
• rates of continuous abstinence
• percentage of days … • time to heavy drinking/relapse
2. reduction in alcohol consumption
• number of heavy drinking days … • percent of subjects with no heavy drinking days
• number of drinking days
• drinks per drinking
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/child-growth-development-outcomes-protocol.pdf
August 19, 2024 - described
by the Developmental Origins of Health and Disease (DOHaD),9-11 and supported by the ‘1st
1000 Days … PMID: 19711246.
12. 1 D. 1,000 Days. https://thousanddays.org/about/. . … Improving Nutrition in the First 1000 Days in
the United States: A Federal Perspective.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation_executive.pdf
June 01, 2012 - Consciousness/Mental State A moment to 24 hours >24 hours >24 hours
Post-traumatic Amnesia 0–1 day >1 and <7 days … >7 days
Glasgow Coma Scale (best available score
in 24 hours)
13–15 9–12 3–8
Abbreviated Injury
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/home-dialysis-ESKD-rapid-research.pdf
April 01, 2025 - that he can’t do it by
himself, the traditional route would be to get him to spend the last
of his days … authors found the intent for temporary assistance was realized: the median duration in
the program was 8 days … Canada
Bevilaqua
201725
Trained
caregivers
Once-daily home visits of up to 1 hour, up to 7 days … Long-term or respite
[12-month pilot;
For respite care:
median time to return
to self-care 29 days … to gain
independence (details of
training NR)
Start-up
[Up to 3 months
(Median duration: 17
days
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule_research-protocol.pdf
March 14, 2012 - medications such as narcotics, motility agents, and glucagon- like peptide agonists be withheld
for 5 to 7 days … on day 0 and then taking x-ray images at intervals to document the
excretion of those markers by 5 days … An advantage of colon scintigraphy is that testing can be completed
in 1 to 2 days.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - Intervention(s)
and
Comparison
Route of Administration, Dose,
and Duration
Length of
Followup
(Days
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
December 31, 2013 - high-cholesterol-medicines-update-protocol-130516
Evidence-based Practice Center Systematic Review Protocol
Project Title: Update of Comparative Effectiveness of
Lipid-Mod…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
January 31, 2013 - of the disease, called critical limb ischemia
(CLI)—defined as ischemic rest pain for more than 14 days … regimens were generally supervised and lasted between
3 and 12 months, with outcomes measured between 14 days … will be considered when evaluating the benefits and risks of
IC and CLI therapies: short term (≤30 days … ), intermediate term (31 days to 1 year),
and long term (>1 year) … benefits and risks
of intermittent claudication and critical limb
ischemia therapies: short term (≤30 days
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
January 01, 2012 - patients would also need access to a highly trained, multidisciplinary
care team 24 hours a day, 7 days … The recommended dose for ranibizumab is 0.3 mg (0.05 mL) once
monthly (every 28 days) by intravitreal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
August 01, 2017 - Management of Insomnia Disorder in Adults: Current State of the Evidence
Management of Insomnia Disorder in Adults:
Current State of the Evidence
Focus of This Summary
This is a summary of a systematic review that evaluated current evidence regarding the effectiveness, comparative effectiveness,
and adverse effec…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-protocol-amended.pdf
June 10, 2018 - Acute pain typically lasts up to 7 days but may last up to 30 days,
with its duration determined in
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-economics_research.pdf
January 01, 2011 - sum of the payment amount
and the total per diem amount (per diem rate multiplied by the number
of days … sum of the payment amount and the total per diem amount
(per diem rate multiplied by the number of days
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mrsa-screening_research.pdf
June 01, 2013 - using polymerase chain reaction (PCR), intermediate
turnaround time (results available next day to 2 days … after testing performed) or longer
turnaround time (results available greater than 2 days after testing … All teleconference call materials were distributed a few
days prior to scheduled calls. … §CCS Studies
‡ Patient days
A-3
References
1. … e.g., should
elective admissions be screened 7-
10 days prior to admission to avoid
delays?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
September 01, 2009 - Layout 1
Background
Over 28 million Americans have some
form of cardiovascular disease (CVD),
which causes more deaths than cancer,
diabetes, accidents, and chronic lung
diseases combined. Estimated direct
medical expenditures and lost productivity
from CVD amounted to $431.8 billion in
the United States in 2007.
…